医疗设备服务提供商InfuSystems Holdings Inc宣布,由于公司对生物医学服务合同组合进行结构性调整,预计自2026财年起,年营业收入将缩减至710万美元水平。此次业务重组旨在优化长期服务资源配置,但短期内将对整体营收规模产生阶段性影响。
医疗设备服务提供商InfuSystems Holdings Inc宣布,由于公司对生物医学服务合同组合进行结构性调整,预计自2026财年起,年营业收入将缩减至710万美元水平。此次业务重组旨在优化长期服务资源配置,但短期内将对整体营收规模产生阶段性影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.